TEST BANK - Pharmacotherapeutics for Advanced Practice: A Practical Approach Fifth Edition( Virginia Poole Arcangelo, 2026)All chapters

FULLTEST
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCED
x
x




x x
x




x x




PRACTICE APRACTICAL APPROACH5TH
x x x x x




EDITIONBYVIRGINIAPOOLEARCANGELO;ANDREWx x x x x




PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
x x x x x x




PRINTED PDF IORIGINAL DIRECTLY FROM THE PUBLISHER I1OO%
x x x x x x x x x




VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELYAFTER THE ORDER
x x x x x x x




['LIZ)LI12%5IL!


[LI.GIL


Complete Test bank, All Chapters are included.
x x x x x x




For more Test banks, ATI, HES! exams, and more contact us.
x x x x x x x x x x

, Tableofcontent x x




Chapter I Issues for the Practitioner in Drug Therapy
x x x x x x x x




Chapter 2 Pharmacokinetic Basis ofTherapeutics and Pharmacodynamic Principles
x x x x x x x x




Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Chapter
x x x x x x x x x x x x




4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation Chapter 5
x x x x x x x x x x x




Pharmacotherapy Principles in Older Adults
x x x x x




Chapter 6 Principles of Antimicrobial Therapy Chapter
x x x x x x




7 Pharmacogenomies
x x




Chapter 8 The Economics of Pharmacotherapeutics
x x x x x




Chapter 9 Pharmacotherapy of Pain Management
x x x x x x




Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
x x x x x x x x x




Chapter 11 Cannabis and Pain Management
x x x x x x




Chapter 12 Contact Dermatitis
x x x




Chapter 13 Fungal, Viral, and Bacterial Infections ofthe Skin
x x x x x x x x x




Chapter 14 Psoriasis
x x x




Chapter I5 Acne Vulgaris and Rosacea Chapter
x x x x x x




16 Ophthalmic Disorders
x x x




Chapter I7 Otitis Media and Otitis Externa
x x x x x x




Chapter I8 Hypertension
x x x




Chapter I9 Hyperlipidemia
x x




Chapter 20 Chronic Stable Angina and Myocardial Infarction
x x x x x x x




Chapter 2I Heart Failure
x x x x




Chapter 22 Arrhythmias
x x




Chapter 23 Respiratory Infections
x x x




Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Chapter
x x x x x x x x




25 Gastric, Functional, and Inflammatory Bowel Disorders Chapter 26
x x x x x x x x x




Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapter 27
x x x x x x x x x




Liver Diseases
x x




Chapter 28 Urinary Tract Infection
x x x x




Chapter 29 Prostatic Disorders and Erectile Dysfunction Chapter
x x x x x x x




30 Overactive Bladder
x x x




Chapter 3I Sexually Transmitted Infections
x x x x




Chapter 32 Osteoarthritis and Gout Chapter
x x x x x x




33 Osteoporosis
x x




Chapter 34 Rheumatoid Arthritis
x x x




Chapter 35 Headaches
x x x




Chapter 36 Seizure Disorders
x x x




Chapter 37 Alzheimer's Disease
x x x x




Chapter 38 Parkinson's Disease
x x x x




Chapter 39 Major Depressive Disorder and Bipolar Disorders
x x x x x x x




Chapter 40 Anxiety Disorders
x x x x




Chapter 41 Sleep Disorders
x x x




Chapter 42 Attention Deficit Hyperactivity Disorder
x x x x x




Chapter 43 Substance Use Disorders
x x x x x




Chapter 44 Diabetes Mellitus
x x x




Chapter 45 Thyroid and Parathyroid Disorders
x x x x x

,Chapter 46 Allergies and Allergic Reactions
x x x x x




Chapter 47 Human Immunodeficiency Virus
x x x x x




Chapter 48 Organ Transplantation
x x x x




Chapter49Thromboembolic Disorders
x x x




Chapter 50 Anemias
x x x




Chapter 5l Immunizations
x x




Chapter 52Smoking Cessation
x x x x




Chapter 53 Weight Loss Chapter
x x x x x




54 Contraception
x x




Chapter 55 Menopause
x x




Chapter 56 Vaginitis
x x

, lOMoAR x cPSD|

x 21007614




lOMoAR x cPSD| x 21007614




Chapter 1 Issues for the Practitioner in DrugTherapy
x x x x x x x x




MULTIPLE CHOICE x




1. Nurse practitioner prescriptive authority is regulated by:
x x x x x x




A. The National Council of State Boards of Nursing
x x x x x x x




B. The U.S. Drug Enforcement Administration
x x x x




C. The State Board of Nursing for each state
x x x x x x x




D. The State Board of Pharmacy
x x x x




ANS: C x PTS: 1 x




2. Physician Assistant (PA) prescriptive authority is regulated by:
x x x x x x x




A. The National Council of State Boards of Nursing
x x x x x x x




B. The U.S. Drug Enforcement Administration
x x x x




C. The State Board of Nursing
x x x x




D. The State Board of Medical Examiners
x x x x x




ANS: D x PTS: 1 x




3. Clinical judgment in prescribing includes:
x x x x




A. Factoring in the cost to the patient of the medication prescribed
x x x x x x x x x x




B. Always prescribing the newest medication available for the disease process
x x x x x x x x x




C. Handing out drug samples to poor patients x x x x x x




D. Prescribing all generic medications to cut costs x x x x x x




ANS: A x PTS: 1 x




4. Criteria for choosing an effective drug for a disorder include:
x x x x x x x x x




A. Asking the patient what drug they think would work best for them
x x x x x x x x x x x




B. Consulting nationally recognized guidelines for disease management x x x x x x




C. Prescribing medications that are available as samples before writing a prescription
x x x x x x x x x x




D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
x x x x x x x




x prescribing
ANS: B x PTS: 1 x




5. Nurse practitioner practice may thrive under health-care reform due to:
x x x x x x x x x




A. The demonstrated ability of nurse practitioners to control costs and improve patient
x x x x x x x x x x x




x outcomes
B. The fact that nurse practitioners will be able to practice independently
x x x x x x x x x x




C. The fact that nurse practitioners will have full reimbursement under health-care
x x x x x x x x x x




reform
x




D. The ability to shift accountability for Medicaid to the state level
x x x x x x x x x x




ANS: A x PTS: 1 x